Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Twist Bioscience Proposes $250M Public Offering

Twist Bioscience Proposes $250M Public Offering

Dec 02, 2020
|
staff reporter

NEW YORK – Twist Bioscience said on Tuesday that it intends to offer shares of its common stock worth $250 million. Certain selling stockholders intend to offer 75,000 shares in the offering.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Quick Changes If Needed

Moderna says it would be able to quickly update its SARS-CoV-2 vaccine to address new genetic variants if needed, MIT's Technology Review reports.

Early Results on Johnson & Johnson's SARS-CoV-2 Vaccine

Johnson & Johnson reports interim results from a Phase 1/2 study of its SARS-CoV-2 vaccine in the New England Journal of Medicine, according to Bloomberg.

WHO Team Arrives

Investigators from the World Health Organization have arrived in China to look into the origins of SARS-CoV-2, NPR reports.

Nature Papers Present Amplicon Sequencing Approach, Dire Wolf Genomes

In Nature this week: a new method for high-throughput amplicon sequencing, and more.

What's Popular?

In Business News

  1. JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

  2. JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher

  3. JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More

  4. Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

  5. Pacific Biosciences, Invitae to Develop Clinical Whole-Genome Sequencing Platform

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.